What was recalled
This page synthesizes the menadione regulatory and consumer-facing framework in pet food. Vitamin K is a fat-soluble vitamin essential for blood clotting factor synthesis. The natural forms include: vitamin K1 (phylloquinone) from leafy green vegetables; vitamin K2 (menaquinone, MK-4 through MK-13) from animal sources and gut bacterial synthesis; and the synthetic vitamin K3 (menadione) developed for cost-effective vitamin K supplementation. Menadione is approximately 30-300 times cheaper than vitamin K1 on a unit-activity basis, making it the dominant vitamin K source in commercial pet food and animal feed.
The U.S. FDA approves menadione for animal feed use under 21 CFR 573.620 (menadione sodium bisulfite complex) and 21 CFR 573.640 (menadione dimethylpyrimidinol bisulfite). The approved use levels are calibrated to provide adequate vitamin K activity while staying well below the doses associated with hepatotoxicity and hemolytic effects in toxicology studies. The European Union and most other jurisdictions follow similar regulatory frameworks for animal feed use of menadione. Human supplement use of menadione was prohibited by the FDA in the 1980s following documented adverse events in pediatric clinical use including hemolytic anemia, hyperbilirubinemia, and kernicterus in newborns receiving menadione injections. The species-difference rationale for the human ban vs animal feed approval rests on dose-response data and species-specific metabolism differences.
Why it was recalled
The structural controversy is that the regulatory split (banned for human supplements, approved for animal feed) does not resolve the consumer-facing question of whether to feed a synthetic vitamin form banned for human use to pets. Pet owners can choose: (1) menadione-containing pet food at FDA-approved use levels for adequate vitamin K activity at low cost; (2) vitamin K1-supplemented pet food using natural phylloquinone from plant sources at substantially higher ingredient cost; (3) vitamin K-adequate-without-supplementation formulations relying on dietary vitamin K from named-species animal protein and ingredient diversity. Most premium-tier brands offer vitamin K1-supplemented formulations as a positioning element; mid-tier and value-tier brands typically use menadione.
The toxicology framework for menadione in pet feeding includes: (1) acute toxicity studies in dogs at doses substantially above feeding levels showing hemolytic anemia, hyperbilirubinemia, and hepatotoxicity; (2) chronic feeding data at FDA-approved use levels showing no consistent adverse effects in dogs and cats; (3) species-difference data showing greater menadione tolerance in adult dogs and cats than in human infants (driving the human supplement ban specifically focused on pediatric use); (4) idiosyncratic reactions in some pets that may produce hepatic or hematologic abnormalities at the regulated feeding doses. The data set supports current regulatory framework but the chronic-feeding-at-low-doses long-term data is less comprehensive than modern toxicology study protocols would generate. The FDA pet food information documents the regulatory framework.
Health risks for your pet
Documented health risks from menadione include: (1) hemolytic anemia, hyperbilirubinemia, and kernicterus in human pediatric use (driving the human supplement ban); (2) hepatotoxicity at elevated doses in toxicology study formats; (3) idiosyncratic reactions in some pets that may produce hepatic or hematologic abnormalities. At the FDA-approved use levels in pet food, the documented adverse event rate is low and the regulatory framework treats menadione as safe for pet feeding. For consumers prioritizing precautionary positioning, vitamin K1 (natural phylloquinone) supplementation provides the alternative without the consumer-facing concern. For pets with diagnosed hepatic disease or coagulopathy, veterinary nutritionist consultation can address specific vitamin K supplementation considerations.
What to do if you bought affected product
Pet owners can navigate the menadione question through: (1) ingredient deck inspection — menadione typically appears as "menadione sodium bisulfite complex," "menadione dimethylpyrimidinol bisulfite," or simply "menadione" in the ingredient list, usually near the end of the vitamin/mineral premix section; (2) premium brand selection — most premium brands offer vitamin K1-supplemented formulations or rely on dietary vitamin K from named-species animal protein; (3) label transparency — brands publishing complete vitamin/mineral premix ingredient sourcing provide higher transparency than brands using generic "vitamin supplement" language; (4) pediatric and senior pet considerations — puppies, kittens, and senior pets with reduced hepatic function may benefit from natural vitamin K1 supplementation if available, though the FDA-approved menadione use levels do not produce documented adverse effects in these populations. The ethoxyquin preservative controversy covers a related synthetic-additive framework debate.
How this affects KibbleIQ’s grade
The KibbleIQ rubric v15 weights vitamin K1 (natural phylloquinone) supplementation favorably over menadione (synthetic vitamin K3) per our published methodology. Formulations using vitamin K1 receive scoring advantage over formulations using menadione, reflecting precautionary positioning toward natural vitamin forms even where the synthetic forms meet FDA regulatory standards. The structural rationale parallels the rubric’s preference for tocopherol-based preservation over ethoxyquin and natural antioxidant systems over synthetic preservatives. The persistent consumer-facing concern about menadione drives premium-tier brand transition to vitamin K1 supplementation, and the rubric scoring framework reflects this market positioning.